index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

87

 

NOTICES

152

 

 

MOTS CLES

Anticancer drugs CTLA-4 Burden Psoriasis Axial spondyloarthritis Aging Acute Myeloid Leukaemia AML Treatment Antimicrobial Stewardship Biologic Antibiotic resistance Atrial fibrillation Quality of life Atopic dermatitis Intensive care Etanercept Antimicrobials Autoimmune diseases Antibiotics ArtThese Anti-TNF Anti-HCV Direct Acting Antivirals DAA Biologic drug Dermatology Stability Adverse side effects Vigibase® Glucocorticoids Ethics Prostate cancer BTK protein Antimicrobial resistance Apre-milast CSK tyrosine-protein kinase Bacterial Endocrine toxicity Pharmaco-Épidémiologie Azathioprine Biological therapy Angiotensin receptor blockers Anti-Bacterial Agents Drug survival Cardiotoxicity Auto-immune hepatitis COVID-19 Pharmacoepidemiology Pharmacovigilance Placebo Immunotherapy Biomédicaments Anxiety Biologics Arrhythmia Infliximab Biomarkers Epidemiology Management Psoriatic arthritis Abus d'antibiotiques Cardio-oncology Auto-Diagnostic Antimicrobiens Biologic therapy Biosimilar Pharmaceuticals Sacroiliitis Alcohol Calcium channel blockers Immune checkpoint inhibitors Alitretinoin Méta-Analyse Cardiomyopathy Apremilast Arthritis Antibiotic misuse Adolescent Amyloidosis Meta-Analysis Ankylosing spondylitis Accelerometer Pregnancy Cancer ASDAS Albinism Biological Therapy Access to care Ustekinumab Autoimmunity Bacterial rhinosinusitis Beta-lactam antibiotics Anxiété Adalimumab Angiotensin-converting enzyme inhibitors Primary adrenal insufficiency Graft-versus-host disease Sipuleucel-T Drug reaction Ankylosing Spondyloarthritis Addiction Immune-related adverse events

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS